sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Disclosure on Spire Healthcare
The Vanguard Group, Inc. has released Form 8.3 related to its interests in Spire Healthcare Group plc. As of February 20, 2026, Vanguard holds 14,509,826 shares, representing a 3.60% stake in Spire Healthcare's 1p ordinary shares. This information is disclosed as per Rule 8.3 of the Takeover Code.
The disclosure notes a recent sale of 6,425 ordinary shares at a price of 2.00 GBP per share. No cash-settled or stock-settled derivatives were reported in this disclosure, and there are no current indemnity or dealing arrangements in place.
Vanguard states that there are no agreements or understandings regarding voting rights or future transactions involving Spire Healthcare securities. No Supplemental Form 8 has been attached, indicating no open stock-settled derivatives or agreements exist.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.